Utility of serum and urinary transforming growth factor-beta levels as markers of diabetic nephropathy

被引：20

作者：

Mogyorósi, A

Kapoor, A

Isono, M

Kapoor, S

Sharma, K

Ziyadeh, FN

机构：

[1] Virginia Commonwealth Univ, Med Coll Virginia, Div Nephrol, Dept Med, Richmond, VA 23298 USA

[2] McGuire VAMC, Richmond, VA USA

[3] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA

[4] Thomas Jefferson Univ, Dept Med, Div Nephrol, Philadelphia, PA 19107 USA

来源：

NEPHRON | 2000年 / 86卷 / 02期

关键词：

D O I：

10.1159/000045766

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

页码：234 / 235

页数：2

共 5 条

[1]

Fagerudd JA., 1997, KIDNEY INT SUPPL, V63, P195, DOI [10.1038/ki.1997.508, DOI 10.1038/KI.1997.508]

[2]

Mogyorosi A, 1996, Curr Opin Nephrol Hypertens, V5, P243, DOI 10.1097/00041552-199605000-00010

[3]

Elevated plasma levels at transforming growth factor-beta 1 in NIDDM [J].

Pfeiffer, A ;

MiddelbergBisping, K ;

Drewes, C ;

Schatz, H .

DIABETES CARE, 1996, 19 (10) :1113-1117

[4]

Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy [J].

Sato, H ;

Iwano, M ;

Akai, Y ;

Kurioka, H ;

Kubo, A ;

Yamaguchi, T ;

Hirata, E ;

Kanauchi, M ;

Dohi, K .

AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (06) :490-494

[5]

Increased renal production of transforming growth factor-beta(1) in patients with type II diabetes [J].

Sharma, K ;

Ziyadeh, FN ;

Alzahabi, B ;

McGowan, TA ;

Kapoor, S ;

Kurnik, BRC ;

Kurnik, PB ;

Weisberg, LS .

DIABETES, 1997, 46 (05) :854-859

← 1 →